Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today ...

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical ...

The global communications group will unite six agencies under one roof in a purpose-built, hybrid workspace at the heart of ...

The US Food and Drug Administration (FDA) has announced the publication of more than 200 complete response letters (CRLs), ...

Merck & Co – known as MSD outside of the US and Canada – has announced that it will be expanding its respiratory diseases ...

While the year started out as cautiously optimistic, stemming from the peak of biotech initial public offering (IPO) activity ...

The European Commission (EC) has approved Biocon Biologics’ biosimilars referencing Amgen’s bone disease therapy denosumab.

The US Food and Drug Administration (FDA) has granted accelerated approval to Dizal’s Zegfrovy (sunvozertinib) to treat a ...

The phase 3 FORTITUDE-101 trial, conducted with the support of Zai Lab, has been evaluating bemarituzumab plus mFOLFOX6 ...

“ [These] strong phase 3 efficacy results are a significant milestone in our effort to reduce the burden of influenza in ...

A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of ...

Biogen has announced that it has initiated a phase 3 study of investigational felzartamab in adults with primary membranous ...